{"description":"All adverse events (AEs) (except non-serious AEs for screening failures) that occurred after the provision of informed consent and up to 30 days after last study drug administration was recorded in the eCRF and in the participant's medical records, whether or not they were considered by the investigator to be related to the study drug. Thereafter, only AEs assessed as related were collected at the end of the study.","eventGroups":[{"deathsNumAffected":45,"deathsNumAtRisk":81,"description":"MOR00208 was administered via intravenous Infusion, weekly (Cycle 1-3) of the study each cycle consisted of a MOR00208 infusion on Day 1, Day 8, Day 15 and Day 22 of the cycle. Additionally, a loading dose was administered on Day 4 of Cycle 1. Thereafter MOR00208 was administered on a bi-weekly (every 14 days) basis with infusions on Day 1 and Day 15 of each 28-day cycle, until disease progression or unacceptable toxicity or discontinuation due to any other reason.\n\nLenalidomide (Revlimid®), PO, daily, on Days 1-21 of each cycle, for up to 12 cycles in total. LEN dose could be modified in a de-escalating fashion or discontinued based upon clinical and laboratory findings. Treatment with LEN was stopped in case of disease progression, or unacceptable toxicity, or discontinuation for any other reason.\n\nOn days when both study drugs were given together, LEN was administered prior to tafasitamab.","id":"EG000","otherNumAffected":75,"otherNumAtRisk":81,"seriousNumAffected":47,"seriousNumAtRisk":81,"title":"Treatment (MOR00208, Lenalidomide)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":40,"numAtRisk":81,"numEvents":215}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":30,"numAtRisk":81,"numEvents":74}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":81,"numEvents":71}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":81,"numEvents":44}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":6}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":10}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":30,"numAtRisk":81,"numEvents":63}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":81,"numEvents":21}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":81,"numEvents":21}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":81,"numEvents":15}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":9}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":81,"numEvents":39}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":81,"numEvents":35}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":81,"numEvents":39}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":81,"numEvents":24}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":9}],"term":"Mucosal inflammation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":81,"numEvents":19}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":11}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":81,"numEvents":17}],"term":"Respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":9}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":81,"numEvents":15}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":9}],"term":"Gastroenteritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":81,"numEvents":20}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":81,"numEvents":28}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":26}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":16}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":81,"numEvents":19}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":81,"numEvents":16}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":913}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":11}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":81,"numEvents":36}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":81,"numEvents":16}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":6}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":81,"numEvents":12}],"term":"C-reactive protein increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":81,"numEvents":17}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":9}],"term":"Gamma-glutamyltransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":9}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":81,"numEvents":10}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":81,"numEvents":19}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":81,"numEvents":7}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":81,"numEvents":10}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":6}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":10}],"term":"Anxiety"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":5}],"term":"Hypogammaglobulinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":5}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":5}],"term":"Dysuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":9}],"term":"Blood alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":5}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":8}],"term":"Sciatica"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":5}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":18}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":81,"numEvents":7}],"term":"Rhinitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":7}],"term":"Sinusitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":81,"numEvents":8}],"term":"Abdominal pain upper"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":81,"numEvents":7}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":2}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":2}],"term":"Bronchopulmonary aspergillosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Cytomegalovirus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Enterobacter bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Escherichia bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Febrile infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Influenza"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Klebsiella sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":4}],"term":"Lower respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Neutropenic sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Parainfluenzae virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Progressive multifocal leukoencephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Respiratory syncytial virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":2}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Soft tissue infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Streptococcal sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Urinary tract infection enterococcal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Varicella zoster virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":81,"numEvents":5}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":2}],"term":"Agranulocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":2}],"term":"Atrial fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":2}],"term":"Cardiac failure congestive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Myocardial ischaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Cerebrovascular accident"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Cervicobrachial syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Cognitive disorder"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Facial paralysis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Sciatica"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Transient global amnesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":81,"numEvents":3}],"term":"Pulmonary embolism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":2}],"term":"Chronic obstructive pulmonary disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":2}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Respiratory failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Arthritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Muscular weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Osteonecrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Pathological fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Sudden death"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Femur fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Lower limb fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Wound complication"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":2}],"term":"Squamous cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Tumour flare"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Biliary colic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Renal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Deep vein thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":81,"numEvents":3}],"term":"COVID-19"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"COVID-19 pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Gastroenteritis rotavirus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":81,"numEvents":2}],"term":"Basal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Bowen's disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Breast cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Lung adenocarcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Myelodysplastic syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Prostate cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Transient ischaemic attack"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":2}],"term":"Cholecystitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Haematoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Intervertebral discitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Myeloproliferative neoplasm"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":81,"numEvents":1}],"term":"Cardio-respiratory arrest"}],"timeFrame":"From first day of study drug administration through 30 days after last dose, up to maximum duration of 6.5 years approximately after first participant enrolled."}